<div id="readability-page-1">Scott Braunstein, Chairman and CEO of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), recently executed several stock transactions, according to a filing with the Securities and Exchange Commission. The transactions come as the stock has experienced a significant 94.55% decline over the past year, according to InvestingPro data. Braunstein sold a total of 304,600 shares of Marinus common stock for approximately $167,530. The shares were sold at a...</div>

Marinus制藥

<p>Marinus 製藥的首席執行官 Scott Braunstein 出售了 304,600 股公司股票，交易金額約為 167,530 美元，相關信息在最近的 SEC 文件中披露。此次出售發生在股票價值大幅下跌的背景下，過去一年該股票的價值下降了 94.55%</p>

Marinus Pharma 首席執行官 Scott Braunstein 出售了價值 167,530 美元的股票